The high prevalence of GSTP1 hypermethylation in prostate cancer, HGPIN and in some proliferative inflammatory atrophy lesions indicates that it most likely precedes many other molecular aberrations in prostate carcinogenesis (Nakayama et al, 2003). This evidence concerns the gene GSTP1 and prostate carcinoma.